US Market Study on Animal Drug Compounding: ‘Flavored’ Products to Grab Spotlight


  • Rep Id : XPLREP4146
  • Published On : August, 2019
  • No. of Pages : 79
  • Category : Drug Discovery
  • Publisher : Persistence Market Research

Animal Drug Compounding Market: Introduction

The latest market report by XploreMR on the U.S. animal drug compounding market evaluates the opportunities and current market scenario, and provides insights and updates about the corresponding segments involved in the U.S. animal drug compounding market during the forecast period 2019-2029. The U.S. animal drug compounding market report further exhibits the estimated data for 2019, and forecast data up to 2029 in terms of value (US$ millions). In terms of value, the U.S. animal drug compounding market is expected to grow at ~8% CAGR over the forecast period. The present study exhibits the trends and market dynamics of the animal drug compounding market.

Animal Drug Compounding Market: Report Description

The report explores the U.S. animal drug compounding market for the period 2019 - 2029. The primary objective of the U.S. animal drug compounding market report is to provide insights of the opportunities in the market that are consistently supporting the transformation of U.S. businesses. It is very important to consider that in an ever-wavering economy, we provide the estimated (Y-o-Y) year-on-year growth rate in addition to the compound annual growth rate (CAGR) for the overall forecast, to better understand the analysis and evaluation of the U.S. animal drug compounding market, and to discover equitable opportunities.

Yet another key feature of this report is the estimation of the U.S. animal drug compounding market and the corresponding revenue forecast carried out in terms of absolute dollar opportunity. This is usually not prioritized while forecasting overall market numbers. Absolute dollar opportunity analysis is very essential in evaluating the degree of opportunity that a provider can observe to execute, as well as to contrast the potential resources from a sales perspective in the U.S. animal drug compounding market.

The U.S. animal drug compounding market report starts with an elaborate executive summary, market definition of various segmentations that are included, and their respective shares in the market. The report further incorporates the major macro and micro-economic factors that have an effect on the growth of the animal drug compounding market. The report also highlights various market dynamics, which include the drivers and restraints in the U.S. animal drug compounding market. Current opportunities, as well as on-going trends in the animal drug compounding market are also discussed in this report. The report further underlines the study of the present issues with industrial processing, and opportunities for the animal drug compounding market. It also encompasses the analysis on the U.S. animal healthcare spending, key regulations by FDA for animal drug compounding, and comparative analysis between 503a and 503B pharmacies. In order to provide users with a clear view of the U.S. animal drug compounding market, we have exhibited a competitive analysis of key market players and their strategic expansions. The competitive dashboard presents a detailed comparison of compounding pharmacies on valuable parameters such as key product offerings, total revenue, key developments, and strategies. The study intensifies the U.S. animal drug compounding market attractiveness analysis by product type, animal type, and formulation.

To evaluate the overall market size of the U.S. animal drug compounding, the report considers various fundamental aspects based on secondary research. Furthermore, it emphasizes on quantitative evaluation such as market share by product type, animal type and formulation. Other qualitative data from primary respondents, which has been consolidated to arrive at clear and accurate market estimations is included. The market size was benchmarked, taking into consideration the U.S. animal drug compounding production. U.S. animal drug compounding production data is obtained from sources such as American Veterinary Medical Association, Professional Compounding Centers of America, company websites, and research publications.

Animal Drug Compounding Market: Competition Analysis

Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, Sixth Avenue Medical Pharmacy, Doughertys Pharmacy, Triangle Compounding Pharmacy Inc., Medisca Inc., Wedgewood Pharmacy, Millers Pharmacy, are the major players involved in the U.S. animal drug compounding market.

Animal Drug Compounding Market: Segmentation

The subsequent sections analyze the U.S. animal drug compounding market on the basis of product type, animal type, and formulation to present a forecast for the period 2019–2029. The market is segmented as follows:

On the basis of type, the U.S. animal drug compounding market has been segmented as –

  • CNS Agents
  • Anti-Infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others

On the basis of animal type, the U.S. animal drug compounding market has been segmented as –

  • Companion Animals
    • Dogs
    • Cats
    • Others
  • Livestock Animals

On the basis of formulation, the U.S. animal drug compounding market has been segmented as –

  • Oral
  • Injectable
  • Others

XploreMR Research Methodology

XploreMR is committed to providing unbiased market research solutions to its clients. XploreMR follows a robust methodology for deducing the data that is included in this report. A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period. This methodology is based on the use of standard market structures, methods, and definitions that are based on inputs from local sources in U.S. Our main sources of research include,

  • Primary Research
  • Secondary Research
  • Trade Research
  • Social Media Analysis

Us Animal Drug Compounding Market